Australia Unemployment Data Due On Thursday
(RTTNews) - Australia will on Thursday release March figures for unemployment, highlighting a light day for Asia-Pacific economic activity.
The Australian economy is expected to add 7,200 jobs after jumping 116,500 jobs in February. The jobless rate is expected to tick up to 3.9 percent from 3.7 percent in the previous month.
Japan will see March results for its tertiary industry activity index, with forecasts suggesting a score of 0.80 following the 0.30 reading a month earlier.
Hong Kong will provide March data for unemployment; in February, the jobless rate was 2.9 percent.
read more
Lowe's Q1 Earnings Down, But Beat Market; Backs FY24 View; Stock Up
Home improvement major Lowe's Companies, Inc. on Tuesday maintained its fiscal 2024 earnings and sales outlook after reporting weak results in its first quarter. However, the quarterly earnings per share were above market estimates. In pre-market activity on the NYSE, Lowe's shares were gaining around 3.1 percent...
RTTNews
|
4小時2分鐘前
Alvotech Partners Dr. Reddy's To Bring AVT03 Biosimilar To Prolia & Xgeva To U.S., Europe, And U.K
Biotech company Alvotech (ALVO) and Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd. (RDY), announced Tuesday that the companies have entered into a license and supply agreement for the commercialization of AVT03, Alvotech's biosimilar candidate to Prolia and Xgeva (denosumab).
RTTNews
|
4小時17分鐘前
Bay Street Likely To Open Lower; Inflation Data In Focus
Canadian shares may open with a negative bias Tuesday morning, tracking weak global markets, and lower commodity prices. Canadian inflation data is likely to make a significant impact on sentiment.
RTTNews
|
4小時21分鐘前
Citius Pharma Announce Positive Topline Results For Pivotal Phase 3 Clinical Trial Of Mino-Lok
Biopharmaceutical company Citius Pharmaceuticals, Inc. (CTXR) announced Tuesday positive topline results of its pivotal Phase 3 clinical trial of Mino-Lok, a novel antibiotic lock solution designed to salvage catheters in patients with central line-associated infections (CLABSI) or catheter-related bloodstream infections (CRBSI).
RTTNews
|
5小時4分鐘前
Lam Research Board Approves $10 Bln Share Buyback Authorization And 10-for-1 Stock Split
Lam Research Corp. (LRCX) announced Tuesday that its Board of Directors approved a $10 billion share repurchase authorization and a forward split of its outstanding shares of common stock at a ratio of 10:1.
RTTNews
|
5小時26分鐘前
Sensex, Nifty End Narrowly Mixed After Choppy Session
Indian shares ended modestly lower on Tuesday after U.S. Federal Reserve officials tempered investor enthusiasm about potential interest-rate cuts
RTTNews
|
6小時23分鐘前
European Shares Decline On US Rate Concerns
European stocks edged lower on Tuesday following cautious comments from Federal Reserve officials on inflation and the interest rate outlook.
RTTNews
|
7小時17分鐘前
Sanofi, OpenAI To Build AI Software To Boost Drug Development
French drug major Sanofi is teaming with artificial intelligence or AI startup OpenAI, the developer of highly popular generative AI chatbot ChatGPT, as well as Formation Bio, an AI and tech-driven drug developer, to build AI-powered software to accelerate drug development and bring new medicines more efficiently.
RTTNews
|
7小時23分鐘前
